And Pregnancy — Stuffiness

Rhinitis of pregnancy, nasal congestion, gestation, hormonal rhinitis, pregnancy rhinitis, intranasal corticosteroids, sleep apnea in pregnancy. 1. Introduction Pregnancy induces a constellation of physical changes, from the well-known (nausea, fatigue) to the less discussed. Among the latter is persistent nasal stuffiness—a sensation of obstruction, pressure, and difficulty breathing through the nose that is not attributable to infection or allergy. For many women, this is an unexpected and frustrating symptom. A 2021 systematic review found that over one-third of pregnant women experience rhinitis severe enough to alter daily activities, yet fewer than 15% report it to their obstetric provider, often assuming nothing can be done (Orban et al., 2021).

Oral corticosteroids (prednisone) are not indicated for pregnancy rhinitis due to fetal risks (cleft palate, preterm delivery) and should be reserved for life-threatening maternal asthma or autoimmune flare. 5.3 Step 3: Intranasal Antihistamines (Limited Role) Azelastine (Astelin, Astepro) is pregnancy category C. It is not first-line because ROP is not histamine-mediated. However, if a pregnant patient has coexisting allergic rhinitis, azelastine may be added. Oral antihistamines (loratadine, cetirizine) are safe for allergy but do not relieve pregnancy-induced congestion because the mechanism is non-allergic. 5.4 Step 4: Decongestants—Use with Extreme Caution Topical decongestants (oxymetazoline, phenylephrine): These are effective but should be limited to 3 consecutive days to avoid rhinitis medicamentosa (rebound congestion). For severe, intermittent stuffiness (e.g., before sleep), a single dose at bedtime for 1-2 nights is acceptable. stuffiness and pregnancy

Author: [Generated for Academic Review] Date: [Current Date] Publication: Journal of Maternal-Fetal & Neonatal Medicine (Simulated) Abstract Nasal stuffiness is one of the most common yet underappreciated complaints during gestation. Termed "rhinitis of pregnancy" (ROP), this condition affects an estimated 20-40% of pregnant individuals, with some studies reporting up to 65% in the third trimester. Unlike allergic or infectious rhinitis, ROP is a physiological response to the hormonal and hemodynamic shifts of pregnancy. This paper provides a comprehensive examination of the etiology, clinical features, differential diagnosis, maternal and fetal implications, and evidence-based management strategies for pregnancy-related nasal congestion. We argue that while rarely dangerous, chronic stuffiness significantly impairs sleep quality, contributes to snoring and obstructive sleep apnea (OSA), and diminishes overall quality of life. A stepwise, safety-conscious approach to treatment—from conservative measures to intranasal pharmacotherapy—is essential for optimal maternal-fetal outcomes. Unlike allergic or infectious rhinitis